Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)

NCT01449292 is registered in ClinicalTrials.gov with Aeris Therapeutics as lead sponsor.

NCT NCT01449292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01449292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
Lead sponsor
Aeris Therapeutics
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2012
Completion date
November 30, 2013
Enrollment
300 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary emphysema